Erythroblastosis fetalis is a potentially life-threatening blood disorder in a fetus or newborn infant. This article provides a general overview. For more detailed information see the specific disorder:
Erythroblastosis fetalis develops in an unborn infant when the mom and the baby have different blood types. The mother produces substances called antibodies that attack the developing baby's red blood cells.
The most common form of erythroblastosis fetalis is ABO incompatibility, which can vary in its severity.
The less common form is called Rh incompatibility, which more often causes a very severe anemia in the baby.
Specific tests depend on the type of erythroblastosis, but may include:
Complete blood count
Bilirubin level
Blood typing
Review Date: 10/8/2007
Reviewed By: Deirdre O’Reilly, MD, MPH, Neonatologist, Division of Newborn Medicine, Children’s Hospital Boston and Instructor in Pediatrics, Harvard Medical School, Boston, Massachusetts. Review Provided by VeriMed Healthcare Network.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Neonatology
